Arrhythmia/EP
Jul 1, 2009 17:00 EDT
An analysis of Medicare records for over 433 000 patients who received CPR between 1992 and 2005 showed that the rate of survival to hospital discharge hovered at around 18%, in spite of efforts to improve CPR delivery.
Hypertension
Jun 22, 2009 16:00 EDT
People taking the nonprescription dietary supplement marketed under the name Stamina-Rx "should stop using it immediately," the FDA is warning consumers.
Hypertension
Jun 18, 2009 15:15 EDT
A new, low-cost, solar-powered blood-pressure-monitoring device has been shown to be accurate and easy to use and was well accepted by healthcare professionals and patients in a field trial in Africa. This could be a "critical tool" in tackling the global problem of hypertension, said one expert.
Hypertension
Doctors from the Portuguese Society of Hypertension have spearheaded a unique mass-media campaign about the harmful consequences of consuming too much salt, which in turn has led to the Portuguese Parliament approving a law restricting the sodium content of processed foods.
Acute Coronary Syndromes
Investigators say results from this phase 2, dose-escalation study have paved the way for the phase 3 trial, ATLAS ACS 2, already enrolling patients and using the lower two doses, twice daily, identified as having the most desirable risk/benefit profile in the phase 2 study.
Hypertension
Jun 16, 2009 14:30 EDT
A phase 3 study with darusentan in patients with resistant hypertension was encouraging, but the data are still "very, very early," said the researcher who presented the late-breaking trial at the European Hypertension meeting this weekend.
Murmurs
Shelley Wood, managing editor of theheart.org, has won a 2009 National Institute for Health Care Management Journalism and Research Award for her "Myxo ring mix-up" series.
Hypertension
The lead investigator for a controversial new analysis of hydrochlorothiazide says the drug is a "paltry" antihypertensive at the usual doses prescribed (12.5 mg-25 mg/per day) and should not be used as initial therapy. Others, however, offered plenty of caveats for the "provocative" conclusions.
Lipid/Metabolic
Obese children, even those without blood-pressure, lipid, or glucose abnormalities, have significantly higher levels of insulin, adiponectin, fibrinogen, and CRP than lean, age-matched controls, a new study suggests.
Hypertension
The European Society of Hypertension is set to stir up the field of BP guidelines later this year, when it publishes an update to its 2007 recommendations. One key change is the recognition of a level of blood pressure below which could be dangerous to high-risk individuals, the so-called J-curve phenomenon. And the new guidelines will advise tailoring therapy to individual patients, rather than recommending a first-, second- and third-line drug therapy approach.
Prevention
Jun 11, 2009 17:15 EDT
The health hazards of being overweight—as distinct from being obese—are real and should be taken seriously, especially if other risk factors are present, such as glucose intolerance or elevated blood pressure, concludes a new scientific advisory from the American Heart Association.
The Cardiology Show
Apr 2, 2009 15:35 EDT
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
Cardiology panels
Nov 4, 2008 14:31 EST
Dr Melissa Walton-Shirley asks Drs Franz Messerli and Raymond Gibbons for their thoughts on dual RAAS inhibition and on what the future holds for ACE inhibitors and angiotensin-receptor blockers following ONTARGET and TRANSCEND.
Cardiology panels
Oct 15, 2008 09:41 EDT
Join Drs Marc Pfeffer, Philip Poole-Wilson, and Franz Messerli, as they talk about the use of ARBs in patients intolerant of ACE inhibitors, following the unexpected results of the TRANSCEND study, in a spirited debate moderated by heartwire journalist Lisa Nainggolan.
This section is presented in collaboration with the
